Forza Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$827K Hold
5,274
0.25% 90
2026
Q1
$806K Hold
5,274
0.28% 85
2025
Q4
$727K Sell
5,274
-75
-1% -$9.82K 0.26% 86
2025
Q3
$686K Hold
5,349
0.26% 90
2025
Q2
$647K Hold
5,349
0.27% 89
2025
Q1
$596K Hold
5,349
0.27% 93
2024
Q4
$521K Hold
5,349
0.24% 104
2024
Q3
$615K Buy
5,349
+30
+0.6% +$3.4K 0.28% 96
2024
Q2
$566K Hold
5,319
0.29% 94
2024
Q1
$515K Hold
5,319
0.27% 106
2023
Q4
$537K Hold
5,319
0.3% 96
2023
Q3
$542K Buy
5,319
+200
+4% +$20.3K 0.28% 106
2023
Q2
$517K Sell
5,119
-200
-4% -$20K 0.26% 111
2023
Q1
$489K Buy
5,319
+657
+14% +$57.4K 0.25% 118
2022
Q4
$423K Buy
+4,662
New +$393K 0.28% 97

Other funds holding NVS

Forza Wealth Management's NVS Position: Q2 2026 in Review

Forza Wealth Management held its Novartis (NVS) position steady in Q2 2026 at 5,274 shares worth $827K. The position accounts for 0.25% of the portfolio, ranked #90.

Forza Wealth Management first reported a position in NVS in Q4 2022 and has held it in 15 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Forza Wealth Management held 5,274 shares of Novartis worth $827K as of Q2 2026.
  • Forza Wealth Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.25% of Forza Wealth Management's portfolio in Q2 2026, its #90 holding.
  • Forza Wealth Management first reported a position in Novartis in Q4 2022 and has held it in 15 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Forza Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.